PeptidePub Blog

Research findings, pricing news, and vendor analysis across the peptide market.

Posts about Orforglipron

Showing 1 to 7 of 7

Peptide Comparisons10 min read

Foundayo vs Wegovy Pill: Which Oral GLP-1 Fits Buyers in 2026?

Foundayo and the Wegovy pill are both oral GLP-1 options, but they are not interchangeable. Foundayo is the simpler daily pill with no fasting rule, while Wegovy pill has stronger semaglutide continuity, cardiovascular-label context, and clear NovoCare cash-pay pricing.

Read more →
Pricing & Deals9 min read

How to Use the Medicare GLP-1 Bridge on July 1: Eligibility, Prior Authorization, Pharmacy Steps, and Backup Options

The Medicare GLP-1 Bridge starts July 1, 2026 and can bring eligible obesity GLP-1 prescriptions to $50 per month, but only if the patient, indication, drug formulation, prior authorization, and pharmacy claim all line up. Use this checklist to prepare before launch and compare cash-pay backup options if the Bridge does not fit.

Read more →
Provider Comparisons10 min read

Novi vs Eden Health: Which GLP-1 Program Is Better in 2026?

Novi is the better first check for low all-in compounded GLP-1 pricing. Eden Health is better if you want a broader doctor-led marketplace with compounded and brand-name GLP-1 options, but buyers need to add the membership fee before comparing costs.

Read more →

STOP PIECING IT TOGETHER

One article at a time is a slow way to learn peptides.

We wrote the shortcut: five books, 45 compounds, every claim graded by the strength of the real evidence. No hype, no gatekeeping, and free updates for life whenever the market shifts. Most readers say it replaces months of forum digging.

Get the Handbook30-day money-back guarantee. Free updates for life.